We will need 2 Vaccines

World will need more than one Covid-19 vaccine, GSK chief

The world will need more than one Covid-19 vaccine so drug companies must partner in the race to develop the weapons to fight the coronavirus, the GlaxoSmithKline chief executive officer, Emma Walmsley, said on Wednesday.
GlaxoSmithKline Plc and Sanofi SA said on Tuesday they would develop a vaccine to fight the fast-spreading coronavirus. The drugmakers said they expect to start clinical trials for the vaccine in the second half of this year.
If successful, the vaccine would be available in the second half of 2021.
Walmsley said GSK’s partnership with Sanofi brings scale to the attempt to get a Covid-19 vaccine but that there was still an enormous amount of work to do.

Emma Walmsley, CEO of GlaxoSmithKline, said the vaccine GSK is developing with Sanofi could be available in 2021.
 Emma Walmsley, CEO of GlaxoSmithKline, said the vaccine GSK is developing with Sanofi could be available in 2021. Photograph: REX/Shutterstock

“The world’s going to definitely need more than one vaccine when you think about demand in this hugely challenged global health crisis,” she told the BBC.
The adjuvanted vaccine will be developed by combining Sanofi’s S-protein Covid-19 antigen and GSK’s pandemic adjuvant technology. Walmsley added:

It normally takes a decade, sometimes even more, to develop a vaccine but obviously we are in an unprecedented situation, the need is incredibly urgent.
We are partnering with regulators to try and go as fast as we safely can.

Comments

Post a Comment

Popular posts from this blog

autopsy reveal on covid patients.

( there is still so much we don't know, but don't be mistaken, this disease is unpredictable and certainly not going away any time soon)  Autopsies on people who died of the coronavirus are helping doctors understand how the disease affects the body -- and one of the most remarkable findings concerned blood clotting, a pathologist says. Dr. Amy Rapkiewicz, the chairman of the department of pathology at NYU Langone Medical Center, spoke to Erin Burnett on OutFront Thursday night. Some Covid-19 patients are known to develop blood clotting issues, but the degree and the extent to which that occurs was described as "dramatic" by Rapkiewicz. In the early stages of the pandemic, bedside clinicians noticed a lot of blood clotting "in lines and various large vessels," she said. "What we saw at autopsy was sort of an extension of that," she said. "The clotting was not only in the large vessels but also in the smaller vessels. ...
Read more

Progression to a Vaccine for Covid and Companies doing the research.

Image
ASK YOURSELF THIS? Do we have a Cure for the following: Common Cold FLU, AIDS, CANCER Why do some people think we will have a CURE for Covid by the FALL 2020? It is important to understand, developing a vaccine cannot be hurried. Here are the steps towards that and the timeline.  I come from a pharma background. Our family is in the medical. pharmaceutical and surgical areas. Clinical trials almost never succeed. We’ve never released a coronavirus vaccine for humans before. Our record for developing an entirely new vaccine is at least four years — more time than the public or the economy can tolerate social-distancing orders.
Read more

Understanding WHY we must be isolated.

Image
distancing may need to continue until 2022, say experts   A security guard controls the distance between commuters on escalators at Catalunya station in Barcelona. Photograph: Jordi Boixareu/Zuma/Rex/Shutterstock Physical distancing measures may need to be in place intermittently until 2022, scientists have warned in an analysis that suggests there could be resurgences of Covid-19 for years to come. The paper, published in the journal  Science , concludes that a one-time lockdown will not be sufficient to bring the pandemic under control and that secondary peaks could be larger than the current one without continued restrictions. One scenario predicted a resurgence could occur as far in the future as 2025 in the absence of a vaccine or effective treatment. Marc Lipsitch, a professor of epidemiology at Harvard and co-author of the study, said: “Infections spread when there are two things: infected people and susceptible people. Unless there is ...
Read more